Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Clinics in Liver Disease · 2023-05 · 27 (2) · 187-210
DOI: 10.1016/j.cld.2023.01.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2023-05. Verfasst von Fernando Bril und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: Fbril@uab.edu. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Metabolic Syndrome, Insulin Resistance. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 150 Literaturangaben. Gefördert von: Gilead Sciences, National Institutes of Health, Eli Lilly and Company.
Abstract (Originalsprache)
The relationship between insulin resistance, metabolic syndrome (MetS), and nonalcoholic fatty liver disease (NAFLD) is complicated. Although insulin resistance is almost universal in people with NAFLD and MetS, NAFLD may be present without features of MetS and vice versa. While NAFLD has a strong correlation with cardiometabolic risk factors, these are not intrinsic components of this condition. Taken together, our knowledge gaps call for caution regarding the common assertion that NAFLD is the hepatic manifestation of the MetS, and for defining NAFLD in broad terms as a "metabolic dysfunction" based on a diverse and poorly understood constellation of cardiometabolic features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: Fbril@uab.edu.
- Division of Gastroenterology, Hepatology and Nutrition, School of Medicine Internal Medicine, Virginia Commonwealth University.
- Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, FL, USA.
Förderung
- Gilead Sciences
- National Institutes of Health
- Eli Lilly and Company
Zitieren
APA
Bril, F., Sanyal, A., & Cusi, K. (2023). Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis. Clinics in Liver Disease, 27(2), 187-210. https://doi.org/10.1016/j.cld.2023.01.002
Vancouver
Bril F, Sanyal A, Cusi K. Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis. Clinics in Liver Disease. 2023;27(2):187-210. doi:10.1016/j.cld.2023.01.002
BibTeX
@article{Bril2023,
author = {Bril, Fernando and Sanyal, Arun and Cusi, Kenneth},
title = {Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis},
journal = {Clinics in Liver Disease},
year = {2023},
volume = {27},
number = {2},
pages = {187--210},
doi = {10.1016/j.cld.2023.01.002}
}
EUVIMED